Chongqing Meijianxing Technology Co., Ltd. was established in 2018. It is a high-tech enterprise focusing on the research and development, production and sales of cardiovascular interventional medical devices. It has 100,000-level and 10,000-level purification workshops that meet GMP standards. The production lines and product raw materials are all from world-class suppliers in Europe and the United States, ensuring the quality of the products. In the competition with similar products at home and abroad, it has been widely recognized by users with higher quality and better prices. The products have passed ISO, CE, FDA, certifications and are exported to dozens of countries and regions such as the United States, Mexico, Germany, Russia, Egypt, Brazil, etc., and have been unanimously recognized and trusted by cooperating hospitals and doctors; the company also pays attention to communication with medical staff and patients, and continuously improves and perfects the humanization of products; maintains good cooperative relations with many medical research institutions at home and abroad, and keeps abreast of new developments in international medicine, so that the company is always at the forefront of the industry in terms of information and technology, and constantly devotes itself to the research and development of new products, while adhering to the market commitment of excellence in products.